Hossein Keyvani

InstitutionIran University of Medical Sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 3 publications in August 2020
    All Publications
    Bar chart showing 114 publications over 15 distinct years, with a maximum of 19 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mirzaei R, Attar A, Papizadeh S, Jeda AS, Hosseini-Fard SR, Jamasbi E, Kazemi S, Amerkani S, Talei GR, Moradi P, Jalalifar S, Yousefimashouf R, Hossain MA, Keyvani H, Karampoor S. Correction to: The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19). Arch Virol. 2021 Jul; 166(7):1841. PMID: 33982181.
      Citations:    Fields:    
    2. Ghanei M, Keyvani H, Haghdoost A, Abolghasemi H, Janbabaei G, Reza Jamshidi H, Hosein Ghazale A, Hassan Saadat S, Gholami Fesharaki M, Raei M. The risk factors and related hospitalizations for cases with positive and negative COVID-19 tests: A case-control study. Int Immunopharmacol. 2021 Sep; 98:107894. PMID: 34186280.
      Citations:    Fields:    Translation:Humans
    3. Mobini Kesheh M, Shavandi S, Hosseini P, Kakavand-Ghalehnoei R, Keyvani H. Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions. Biomed Res Int. 2021; 2021:6693909. PMID: 34136572.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    4. Taghinezhad-S S, Mohseni AH, Bermúdez-Humarán LG, Casolaro V, Cortes-Perez NG, Keyvani H, Simal-Gandara J. Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease. Vaccines (Basel). 2021 May 06; 9(5). PMID: 34066443.
      Citations: 3     
    5. Karampoor S, Zahednasab H, Farahmand M, Mirzaei R, Zamani F, Tabibzadeh A, Bouzari B, Ajdarkosh H, Nikkhah M, Hashemi MR, Laali A, Keyvani H. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol. 2021 Aug; 97:107684. PMID: 33932696.
      Citations: 7     Fields:    Translation:Humans
    6. Mirzaei R, Attar A, Papizadeh S, Jeda AS, Hosseini-Fard SR, Jamasbi E, Kazemi S, Amerkani S, Talei GR, Moradi P, Jalalifar S, Yousefimashouf R, Hossain MA, Keyvani H, Karampoor S. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19). Arch Virol. 2021 Jul; 166(7):1819-1840. PMID: 33745067.
      Citations: 9     Fields:    Translation:Humans
    7. Poustchi H, Darvishian M, Mohammadi Z, Shayanrad A, Delavari A, Bahadorimonfared A, Eslami S, Javanmard SH, Shakiba E, Somi MH, Emami A, Saki N, Hormati A, Ansari-Moghaddam A, Saeedi M, Ghasemi-Kebria F, Mohebbi I, Mansour-Ghanaei F, Karami M, Sharifi H, Pourfarzi F, Veisi N, Ghadimi R, Eghtesad S, Niavarani A, Ali Asgari A, Sadeghi A, Sorouri M, Anushiravani A, Amani M, Kaveh S, Feizesani A, Tabarsi P, Keyvani H, Markarian M, Shafighian F, Sima A, Sadjadi A, Radmard AR, Mokdad AH, Sharafkhah M, Malekzadeh R. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. 2021 04; 21(4):473-481. PMID: 33338441.
      Citations: 33     Fields:    Translation:HumansPHPublic Health
    8. Nojomi M, Yassin Z, Keyvani H, Makiani MJ, Roham M, Laali A, Dehghan N, Navaei M, Ranjbar M. Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis. 2020 Dec 14; 20(1):954. PMID: 33317461.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    9. Mirzaei R, Mahdavi F, Badrzadeh F, Hosseini-Fard SR, Heidary M, Jeda AS, Mohammadi T, Roshani M, Yousefimashouf R, Keyvani H, Darvishmotevalli M, Sani MZ, Karampoor S. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Int Immunopharmacol. 2021 Jan; 90:107204. PMID: 33221169.
      Citations: 15     Fields:    Translation:HumansAnimals
    10. Safari S, Keyvani H, Malekpour Alamdari N, Dehghanian A, Razavi Hashemi M, Nemati Honar B, Aminian A. Abdominal Surgery in Patients With COVID-19: Detection of SARS-CoV-2 in Abdominal and Adipose Tissues. Ann Surg. 2020 09 01; 272(3):e253-e256. PMID: 32568751.
      Citations: 12     Fields:    Translation:Humans
    11. Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, Kazemi S, Jeda AS, Darvishmotevalli M, Yousefimashouf R, Keyvani H, Karampoor S. Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Int Immunopharmacol. 2020 Nov; 88:106928. PMID: 32862110.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    12. Mirzaei R, Goodarzi P, Asadi M, Soltani A, Aljanabi HAA, Jeda AS, Dashtbin S, Jalalifar S, Mohammadzadeh R, Teimoori A, Tari K, Salari M, Ghiasvand S, Kazemi S, Yousefimashouf R, Keyvani H, Karampoor S. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020 10; 72(10):2097-2111. PMID: 32770825.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    13. Goodarzi P, Mahdavi F, Mirzaei R, Hasanvand H, Sholeh M, Zamani F, Sohrabi M, Tabibzadeh A, Jeda AS, Niya MHK, Keyvani H, Karampoor S. Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments. Int Immunopharmacol. 2020 Nov; 88:106885. PMID: 32795893.
      Citations: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. Tabibzadeh A, Zamani F, Laali A, Esghaei M, Safarnezhad Tameshkel F, Keyvani H, Jamshidi Makiani M, Panahi M, Motamed N, Perumal D, Khoonsari M, Ajdarkosh H, Sohrabi M, Ghanbari B, Savaj S, Mosavi-Jarrahi A, Karbalaie Niya MH. SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran. Infect Genet Evol. 2020 10; 84:104387. PMID: 32485332.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    Keyvani's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (283)
    Explore
    _
    Co-Authors (137)
    Explore
    _
    Similar People (60)
    Explore
    _